DMD and Duchenne muscular dystrophy: Although dystrophin represents the major target protein to be restored in patients with DMD, it has become clear over the last few years that an improvement of muscle histopathologies through promotion of angiogenesis and reduction of fibrosis can be achieved via a paracrine effect of the injected stem cells [4–6].